Bader H Alsaikhan, Mohamed Ahmad Alsalem, Mohammed Aloqayli, Musaed Almofdhi, Nawaf Najmi, Ziyad Almutairi, Tariq Alnofaie, Manerh Bin Mosa, Abdullah Mohammed Alkhayal, Ghassan Ibrahim Alhajress
Parasitic vessels on preoperative CT are significantly correlated with higher tumor grade and adverse pathological features in RCC. Their identification may serve as a noninvasive imaging biomarker for tumor aggressiveness and assist in preoperative risk stratification.
BACKGROUND: Parasitic (collateral) vessels observed on contrast-enhanced computed tomography (CT) have been associated with aggressive tumor behavior in renal cell carcinoma (RCC). However, their correlation with tumor grade remains insufficiently characterized.
AIMS AND OBJECTIVES: To evaluate the association between the presence of parasitic vessels on preoperative CT scans and histopathological tumor grade in patients with RCC.
MATERIALS AND METHODS: This retrospective cohort study included 306 patients who underwent nephrectomy for histologically confirmed RCC between January 2016 and December 2024 at a tertiary care center. Preoperative CT scans were independently reviewed for the presence of parasitic vessels. Associations between imaging findings and clinicopathological variables were analyzed using Chi-square and t-tests. Significant variables were entered into multivariate logistic regression analysis.
RESULTS: Parasitic vessels were identified in 158 patients (51.6%). Their presence was significantly associated with larger tumor size (>4 cm), higher T stage, lymphovascular invasion, central necrosis, microvascular invasion, rhabdoid features, and higher tumor grade (P < 0.001). Multivariate analysis demonstrated that tumor size >4 cm (AOR 6.920; 95% CI 4.091-11.707), stage 1 and 2 disease, lymphovascular invasion, central necrosis, and grades 1-3 were independent predictors of parasitic vessel presence.
CONCLUSION: Parasitic vessels on preoperative CT are significantly correlated with higher tumor grade and adverse pathological features in RCC. Their identification may serve as a noninvasive imaging biomarker for tumor aggressiveness and assist in preoperative risk stratification.